Daniel C Bowers Selected Research

dabrafenib

1/2017

Targeted MAPK Pathway Inhibitors in Patients With Disseminated Pilocytic Astrocytomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel C Bowers Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 08/2003
12	Glioma (Gliomas) 03/2024 - 02/2002
9	Medulloblastoma 01/2021 - 01/2004
6	Brain Neoplasms (Brain Tumor) 11/2020 - 11/2006
4	Stroke (Strokes) 11/2023 - 02/2002
4	Ependymoma 01/2023 - 07/2011
3	Central Nervous System Neoplasms 01/2021 - 07/2013
3	Disease Progression 01/2020 - 08/2002
3	Neutropenia 01/2020 - 01/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019 - 01/2010
2	Hemorrhage 10/2022 - 01/2020
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2022 - 02/2006
2	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 11/2017
2	Primitive Neuroectodermal Tumors (PNET) 10/2022 - 01/2012
2	Neuroblastoma 10/2022 - 01/2004
2	Microsatellite Instability 01/2021 - 11/2017
2	Turcot syndrome 01/2021 - 01/2019
2	Meningioma (Meningiomas) 04/2020 - 05/2017
2	Diffuse Intrinsic Pontine Glioma 01/2020 - 10/2018
2	Pinealoma (Pineoblastoma) 01/2020 - 01/2020
2	Astrocytoma (Pilocytic Astrocytoma) 05/2013 - 05/2003
2	Leukemia 05/2013 - 11/2006
2	Oligodendroglioma 05/2003 - 08/2002
1	Neurologic Manifestations (Neurological Manifestations) 11/2023
1	Migraine Disorders (Migraine) 11/2023
1	Headache (Headaches) 11/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Necrosis 03/2021
1	Choroid Plexus Carcinoma 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Fatigue 01/2020
1	Thrombocytopenia 3 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Leukoencephalopathies 12/2019
1	Avian Reticuloendotheliosis 10/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2013
1	Plexiform Neurofibroma 12/2012
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2012
1	Pain (Aches) 11/2012
1	Obesity 11/2012
1	Back Pain (Backache) 11/2012

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2011
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2005 - 07/2002
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021 - 11/2017
2	dipinacoline glutamateIBA 01/2020 - 10/2018
2	Growth Hormone (Somatotropin)IBA 01/2019 - 12/2009
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2017
2	Histones (Histone)IBA 05/2014 - 07/2011
2	Sirolimus (Rapamycin)FDA Link 07/2011 - 06/2010
2	Temozolomide (Temodar)FDA LinkGeneric 02/2006 - 01/2005
2	Anticonvulsants (Antiepileptic Drugs)IBA 05/2003 - 07/2002
2	EnzymesIBA 05/2003 - 07/2002
1	Methotrexate (Mexate)FDA LinkGeneric 11/2023
1	Everolimus FDA Link 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022
1	Tuberculin (PPD)IBA 01/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	ProteomeIBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	CarcinogensIBA 11/2017
1	MutagensIBA 11/2017
1	HhAntag691IBA 09/2017
1	trametinibIBA 01/2017
1	dabrafenibIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 05/2014
1	cyclo(Arg-Pro) (CI 4)IBA 07/2013
1	Dihydrotachysterol (AT 10)IBA 07/2013
1	Transcription Factors (Transcription Factor)IBA 05/2013
1	Proto-Oncogene Proteins B-rafIBA 05/2013
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2013
1	Imatinib Mesylate (Gleevec)FDA Link 12/2012
1	Transaminases (Aminotransferases)IBA 12/2012
1	ChemokinesIBA 08/2012
1	Protein CIBA 08/2012
1	Interleukin-5 (Interleukin 5)IBA 08/2012
1	CytokinesIBA 08/2012

Therapy/Procedure

27	Therapeutics 04/2024 - 07/2002
22	Radiotherapy 11/2023 - 02/2002
9	Drug Therapy (Chemotherapy) 10/2022 - 01/2004
2	Immunotherapy 01/2022 - 01/2021
2	Aftercare (After-Treatment) 12/2009 - 05/2009
1	Combined Modality Therapy 12/2022
1	Cranial Irradiation 10/2022
1	Re-Irradiation 03/2021
1	Craniospinal Irradiation 01/2020
1	Consolidation Chemotherapy 10/2019
1	Maintenance Chemotherapy 10/2019
1	Molecular Targeted Therapy 01/2017
1	Chemoradiotherapy 12/2012